Manuel Ramos Vázquez
-
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 4
- Pancreatic and Hepatic Oncology Research 2
-
- Breast Cancer Treatment Studies 3
- Cancer Genomics and Diagnostics 3
-
- Estrogen and related hormone effects 2
-
- Advanced Breast Cancer Therapies 5
- Co-authors
- Miguel MartínRoberto HeggSuzette DelalogeJoyce O’ShaughnessyAlexey ManikhasMario CamponeEmmanuelle di TomasoJulia Beck
- Cited by
- OncologyCancer ResearchGenetics
- Journals
- Journal of Clinical Oncology (10 papers)Cancer Research (1 paper)Annals of Oncology (2 papers)
- Partner nations
- SpainUnited StatesCanada
In The Last Decade
Manuel Ramos Vázquez
18 papers receiving 208 citations
Peers
Comparison fields: 5 of 46
- Oncology 129
- Cancer Research 56
- Genetics 36
- Pulmonary and Respiratory Medicine 92
- Molecular Biology 106
Countries citing papers authored by Manuel Ramos Vázquez
This map shows the geographic impact of Manuel Ramos Vázquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Ramos Vázquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Ramos Vázquez more than expected).
Fields of papers citing papers by Manuel Ramos Vázquez
This network shows the impact of papers produced by Manuel Ramos Vázquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Ramos Vázquez. The network helps show where Manuel Ramos Vázquez may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Manuel Ramos Vázquez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 2 | |
| 4 | 2020 | 4 | |
| 5 | 2018 | 5 | |
| 6 | 2018 | 1 | |
| 7 | 2018 | 6 | |
| 8 | 2016 | 136 | |
| 9 | 2016 | 3 | |
| 10 | 2015 | 1 | |
| 11 | 2013 | 2 | |
| 12 | 2013 | 1 | |
| 13 | Phase II trial of erlotinib plus capecitabine as first-line treatment for metastatic pancreatic cancer (XELTA study). | 2013 | 15 |
| 14 | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 2011 | 18 |
| 15 | 2011 | 2 | |
| 16 | 2009 | 1 | |
| 17 | 2004 | 9 | |
| 18 | 2004 | 2 |
About Manuel Ramos Vázquez
Manuel Ramos Vázquez is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 210 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Advanced Breast Cancer Therapies (5 papers), HER2/EGFR in Cancer Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Breast Cancer Treatment Studies (3 papers), Cancer Genomics and Diagnostics (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Oncology (129 citations), Cancer Research (56 citations) and Genetics (36 citations). Manuel Ramos Vázquez has collaborated with scholars based in Spain, United States and Canada. Frequent co-authors include Miguel Martín, Roberto Hegg, Suzette Delaloge, Joyce O’Shaughnessy, Alexey Manikhas, Mario Campone, Emmanuelle di Tomaso, Julia Beck, Luc Dirix and Manuel Ruíz Borrego. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.